Background: Individuals with attention-deficit/hyperactivity disorder (ADHD) are reported to manifest visual problems (including ophthalmological and color perception, particularly for blue---yellow stimuli), but findings are inconsistent. Accordingly, this study investigated visual function and color perception in adolescents with ADHD using color Visual Evoked Potentials (cVEP), which provides an objective measure of color perception. Method: Thirty-one adolescents (aged 13---18), 16 with a confirmed diagnosis of ADHD, and 15 healthy peers, matched for age, gender, and IQ participated in the study. All underwent an ophthalmological exam, as well as electrophysiological testing color Visual Evoked Potentials (cVEP), which measured the latency and amplitude of the neural P1 response to chromatic (blue---yellow, red---green) and achromatic stimuli. Result: No intergroup differences were found in the ophthalmological exam. However, significantly larger P1 amplitude was found for blue and yellow stimuli, but not red/green or achromatic stimuli, in the ADHD group (particularly in the medicated group) compared to controls. Conclusion: Larger amplitude in the P1 component for blue---yellow in the ADHD group compared to controls may account for the lack of difference in color perception tasks. We speculate that the larger amplitude for blue---yellow stimuli in early sensory processing (P1) might reflect a compensatory strategy for underlying problems including compromised retinal input of s-cones due to hypo-dopaminergic tone. 
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is one of the most frequently diagnosed childhood psychiatric disorders, with worldwide prevalence rates estimated at 5.3%. 1 However, despite the long history of research since its first medical description in 1775, 2 to date, it remains unclear what are the 'deficits' in ADHD. Current theories posit that executive function deficits account for ADHD symptoms. However, according to a substantial number of studies, ADHD is also associated with visual perceptual problems that cannot be explained by executive dysfunction (appendix A). ADHD is a neuro-developmental disorder which is associated with delayed cortical maturation in many regions, including the occipital cortex. 3, 4 Specifically, color perception has been reported to be altered in ADHD population (appendix B). For instance, in our previous study, young adults with ADHD reported significantly more self-perceived visual difficulties in everyday tasks as well as poorer hue discrimination specifically for blue stimuli. 5 Furthermore, children with ADHD have been found to score poorly on clinical tests of blue---yellow color perception, but not red---green, 6, 7 and showed decreased game performance in a virtual environment when important on-screen information was displayed predominantly in blue---yellow colors compared to performance with information displayed in red---green colors. 8 Finally, several studies report decreased speed in color processing in the ADHD population. 9, 10 The possibility of color perception problems in ADHD is of clinical importance, given the extensive use of color in educational settings, as well as the frequent use of color stimuli in many of the standard neuropsychological tests used in the assessment for ADHD and related disorders (e.g. Color-Word Stroop Test, Wisconsin Card Sorting Test, A Quick Test of Cognitive Speed, Rapid Automatized Naming). Color vision mechanisms, particularly the shortwavelength pathway, are particularly vulnerable to insult from toxins, and highly sensitive to CNS drugs and the neurotransmitter, such as dopamine. Accordingly, the ''retinal dopaminergic'' hypothesis of color vision 11 proposes that the dopamine deficiency in central nervous system (CNS) in ADHD population may induce a hypo-dopaminergic tone in the retina, which in turn would have deleterious effects on short-wavelength (S) cones. S-cones are sensitive to blue---yellow light wavelengths and to dopamine (as well as other neurochemical agents), and relatively scarce in number. Thus, the purported low dopaminergic tone in ADHD may have a specific effect on blue color perception. To our knowledge, so far, testing this hypothesis in the ADHD population has solely relied on clinical tests of color perception. Clinical vision tests have been criticized for their requirements for sustained attention and motor coordination, which are known to be impaired in ADHD. 12, 13 Also these tests do not inform about mechanisms underlying poor performance on B ---Y stimuli. In addition, most of these studies have focused on children with ADHD.
Accordingly, this pilot study is aimed to explore the B ---Y color mechanism in an extended population (adolescents with ADHD) using an electrophysiological technique (color visual-evoked potential; cVEP). cVEP provides a noninvasive, sensitive and objective measure of chromatic input in visual pathways. 14 Participants are directed to stare at the stimuli that alternate between 'on' (100 ms) and 'off' (400 ms) while brain waves are measured in the occipital cortex. cVEP is suitable for individuals with ADHD, since it is a purely perceptual task in which the stimuli are presented very briefly, and does not require executive function, sustained or selective attention, or motoric response. To our knowledge, no previous studies examined color perception processing using cVEP in ADHD population. However, children with learning disability have been reported to show less alpha attenuation using parieto-occipital EEGs, suggesting that attention problems may influence learning disability. 15 Poor readers have also been found to manifest significantly lower thresholds/higher sensitivity for B ---Y stimuli than normal readers. 16 By contrast, based on visual pattern electroretinograms, adults with ADHD were not found to show a significantly larger contrast gain than control group, 17 nor were any latency differences (N75, P100, N145) found for children with ADHD using pattern reversal evoked potential. 18 In this study, we measured the neural response (P1) to chromatic and achromatic stimuli, thereby providing a more direct assay of color processing in this population. The P1 component of the cVEP (peak latency 136---146 ms) is an early response to the visual stimuli and it is mainly generated from the dorsal extrastriate cortex where color processing is localized. 19---22 In addition, we conducted an ophthalmological exam (e.g., visual acuity, refraction, fundus exam) to test general visual functions in ADHD. We hypothesized that the adolescents with ADHD would show normal visual function on ophthalmological exam, but altered B ---Y color vision as indexed by both latency and amplitude of P1. Specifically, we expected ADHD group to show deficient neural activity in response to B ---Y stimuli shown as decreased amplitude and prolonged latency of P1 compared to control group.
Methods

Participants
A total of 31 adolescents, aged 13---18 years, participated; 16 (81% male, mean age: 16) with a confirmed DSM-IV 39 diagnosis of ADHD (described below) and 15 (67% male, mean age: 15) healthy controls matched for age, sex, and IQ. No significant differences were found in age and sex between the groups. Adolescents with confirmed ADHD diagnosis were recruited from a larger-scale study on working memory (Canadian Institutes of Health Research operating grant # 11398); those in the comparison group were recruited through notices posted in the research setting (a large pediatric hospital in an urban area). All adolescents participating in the study were native English speakers. Adolescents were excluded if mothers reported a history of major perinatal complications such as prematurity, low birth weight, any history or current presentation of psychosis, comorbid Tourette syndrome, phenylketonuria, autism, or other pervasive developmental disorders. Also adolescents were excluded if they had a history or current use of cocaine or other substances, or had below average intellectual functioning (defined as a standard score of at least 80 on either the Verbal or Performance Scale of the WISC-III). We chose to study adolescents, because they would be able to understand and comply with the cVEP requirements.
The DSM-IV diagnosis of ADHD had been confirmed by a systematic and comprehensive clinical diagnostic assessment conducted within the past one to 2 years, as a part of the larger scale study. Assessment consisted of a semi-structured clinical diagnostic interview [Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version; K-SADS-PL 23 ], as well as the Conners' Rating Scales-Revised, 24 completed by parents and teachers. The K-SADS had been conducted separately with the adolescent and parent, and the clinician summarized the information from both informants. Diagnosis of ADHD in adolescents had been based on the following algorithm: (1) met DSM-IV criteria according to the clinician summary based on the K-SADS-PL interviews; and (2) met the clinical cut-offs for inattentive or hyperactive/impulsive symptoms on the Conners' teacher questionnaires (t-score > 70) to confirm pervasiveness of symptoms across settings.
For the current study, parents of all participants were asked to complete the Strengths and Weaknesses of ADHDsymptoms and Normal Behavior Scale (SWAN 25 ), using a 7-point likert scale for each item (score of '1' indicating the child's abilities were far below those of peers; score of '7' indicating abilities far above those of peers) to index current symptomatology. Total scores for inattention and hyperactivity/impulsivity were computed, with lower scores indicating more problems. Also, parents as well as teachers completed the Strengths and Difficulties Questionnaire (SDQ 26 ) to obtain standardized ratings of current behavior. Adolescents in the comparison group who had any scores in the clinical range were excluded. Informed consent from the participating adolescents and their parents was obtained before the test.
Participants with ADHD who were being treated with stimulant medication (n = 7; 35% of the sample) were requested to stop any stimulant medication for at least 24 h prior to the study. However, since we had no reliable method for confirming that participants had indeed ceased their treatment for more than 24 h, we opted to classify participants with ADHD into two groups: those with and without current medication treatment.
This study was approved by our institutional Research Ethics Board (The Hospital for Sick Children: REB file #1000003973); all participants (adolescents, parents) provided written informed consent prior to commencing the study.
Measures
Ophthalmological exam: a comprehensive vision exam, conducted under specified lighting conditions by a trained ophthalmologist, included the following measures:
-Contrast sensitivity 27 29 It permits recording of an occipital lobe brain wave in response to visual stimulation that begins in the retina and ends at the visual cortex. 30 In the current study, three types of stimuli were used. The first, the achromatic grating was a white-gray luminance stimulus to verify that meaningful VEP signals could be collected. The second was an isoluminant grating for long and medium wavelength color mechanisms (red---green). The third type was an isoluminant S-grating specific for S-cone activation-deactivation (blue---yellow). Achromatic and chromatic stimuli were presented in a patterned onset-offset presentation. This means that the stimulus alternated between ''on'' (for 100 ms) and ''off'' (for 400 ms) at a repeated rate of 2 Hz, until 60 sweeps were collected. The time of luminance presentation consistently occurred between chromatic stimuli so as not to saturate the color vision system. Stimulus parameters were selected to optimize the chromatic response and differentiate between the chromatic and achromatic VEP response (see Elia et al. 31 for the details). Chromatic and achromatic stimuli were produced using Vision Research Graphics (VRG) software (Durhan, NH). Specifically, the red---green color grating consisted of vertical bars varying from red to green with respective chromaticity coordinates of x = 0.3574, y = 0.3099 and x = 0.3064, y = 0.3372. The violet to yellow---green grating consisted of alternating violet (x = 0.2893, y = 0.2496) and yellow---green (x = 0.3409, y = 0.3523) bars. Each of the color stimuli pairs: red and green or blue or yellow were isoluminant. This was to ensure that the cortical responses being recorded arose predominantly from color selective cortical cells and not from luminance-responsive cells. 32 These stimuli were presented on a 21-inch RGB color graphics monitor (FlexScan f930; Eizo, Cypress, CA) with 26
• × 20
• field dimensions. Previous research has demonstrated good test---retest reliability using this large stimulus display with the NeuroScan Aquire 4.0 Program. 33 We positioned 6-mm diameter gold disk electrodes (Genuine F-F5GH; Grass Instrument Division, Astro-Med, Inc., West Warwick, RI) with protected terminals (Safelead; Grass) on the scalp, as stated in the international 10---20 system of electrode placement, on the visual occipital cortex in positions Oz, O1, and O2 along with two additional electrodes on nonvisual areas of the cortex at Pz (ground) and Cz (reference), to obtain cortical responses to color stimuli. The Scalp-electrode impedance was measured after all electrodes are applied to ensure that the impedance was less than or equal to 10 k. Color VEPs were recorded at a viewing distance of 75 cm. Each participant was tested binocularly. A fixation target (central dot) was presented to maintain participants' visual attention. Also, a tester, who was positioned behind the computer, monitored participant's eye gaze and was responsible for starting and stopping the trial if the participant became tired and lost fixation on the stimulus. The trial was restarted once the participant had re-established his/her gaze on the stimulus.
For VEP data analysis, waveforms were recorded for achromatic, L-M and S patterns. Sixty presentations were acquired and averaged for each stimulus, which was presented twice. Thus, a total of 120 presentations per each condition were recorded. We measured both VEP latency as well as amplitude. Since latency of VEP waveform generated by chromatic stimuli (both red---green and blue---yellow) is typically negative wave, in adults, 34 the latency of chromatic onset-offset VEP data was measured from pattern onset to the first negative component. Peak amplitudes were measured from the trough of the first negative wave to the peak of the preceding positive wave for wave generated by chromatic stimuli ( Fig. 1 shows an example for a male participant in this study). The VEP system (NeuroScan Acquire 4.0 program) acquired averaged VEP data from the Synamps amplifier system (NeuroScan, Herdon, Virginia). The sampling frequency was 1000 Hz. The noise level was 2 V peak to peak. The artifact reject was set to ± 100 V, thus, artifacts from non-visual sources such as muscle artifact (i.e. eye blink) would be eliminated. 
Figure 1
A color VEP data of a participant from blue---yellow (S-cone onset) stimuli. Latency (time of response to stimulus) for S response onset is measured from pattern onset (time of stimulus presentation) to the trough of the first large negative wave. Amplitudes of the waveforms were measured from the trough of the first negative wave to the peak of the positive wave. 
Analysis
Data points (behavioral and ERP) with SD's >3 were regarded as outliers and adjusted using a winsorizing technique. 35 This was applied to a total of seven data points: one data point from Left Acuity, Left contrast sensitivity, right spherical correction, Left cylindrical correction, Right cylindrical correction, and 2 data points from red---green latency. Also, 3 control participants were excluded from VEP tests due to weak VEP signals and very low motivations (observed tiredness, boredom and lack of sleep). We used both relatives (difference in luminance to chromatic data) to control for inter-individual variability and also absolute values to analyze amplitude and latency. Planned orthogonal contrast analyses were used to test the hypothesized group differences in color perception and other visual functions. We first compared the ADHD and control groups, and then the medicated versus non-medicated ADHD subgroups. Effect sizes (ES) were calculated using Cohen's d. 36 Conventionally, Cohen's d ranging 0.2---.03 is considered to be a small effect size, 0.5 as medium and 0.8 as large, respectively. No Bonferroni correction for multiple comparisons was applied since this was a pilot study and not adequately powered for repeated measures ANOVA.
Results
Sample characteristics and performance on vision measures are summarized in Tables 1 and 2 , respectively. As expected, adolescents with ADHD showed significantly more inattentive [t(27) = −6.627, p = 0.000] and hyperactivity symptoms [t(27) = −2.990, p = 0.006] than control adolescents based on parent's report on SWAN. Furthermore, the medicated ADHD subgroup tended to show more inattentive symptoms than non-medicated ADHD subgroup, (trend level difference), suggesting that medicated subgroup may present more severe ADHD symptoms (Table 1) . Also, ADHD group showed significantly more overall difficulties in school [t(27) = −4.233, p = 0.000] as well as in home settings [t(27) = 3.304, p = 0.003].
There were no group differences in general vision based on the ophthalmological tests including visual acuity, contrast sensitivity, and refraction. Clinical notes on the fundus exam suggested that the fundus was within normal limits for virtually all participants except 1 participant in each ADHD and Control group (see appendix C for detail).
On VEP measures, using relative values, no significant group differences were found for the P1 latency, but the ADHD group (both medicated and non-medicated participants) showed significantly larger P1 amplitude in response to blue---yellow stimuli than did the comparison group [t(25) = 2.35, p < 0.05; Cohen's d = 0.80, see Fig. 2 ], but the groups did not differ in either latency or amplitude in terms of the P1 response to red---green stimuli [t (24) = 0.183, p = 0.86; Cohen's d = 0.11]. The group differences in P1 amplitude in response to blue---yellow stimuli appear to be driven primarily by the 'medicated' ADHD group, since their P1 amplitude was significantly larger compared to that of the non-medicated subgroup [t(25) = 2.18, p < 0.05; Cohen's d = 0.77]. Similarly, using absolute values, the 'medicated' ADHD group showed significantly larger P1 amplitude for However, the ADHD group overall did not differ from controls in either amplitude or latency of response to blue---yellow and red---green stimuli (see Table 2 ). Moreover, the ADHD subgroups did not differ in either latency Additional analysis was conducted using achromatic stimuli (luminance), although these stimuli were used primarily as an experimental control condition designed to prevent saturation of the color vision system. No significant intergroup differences were found in amplitude or latency for achromatic stimuli (see Table 2 ).
Inattentive symptoms from parent ratings on the SWAN correlated significantly with P1 amplitude in response to B ---Y stimuli [r (27) 
Discussion
This study represents the first attempt to use cVEP to assay color perception in an ADHD sample. Moreover, we conducted ophthalmological testing to allow us to disaggregate color perception problems from problems in vision. The major findings in this pilot study were that: (1) the ADHD group (particularly the 'medicated' group) showed a much larger P1 amplitude in response to blue---yellow stimuli than did the comparison group, but did not differ in terms of the P1 latency; (2) there were no intergroup differences in the P1 amplitude or latency in response to red---green or achromatic stimuli; (3) inattention significantly correlated with the P1 amplitude, only for B ---Y stimuli; and (4) there was no evidence in ophthalmological problems in the ADHD group based on the clinical measures.
The present study yielded several novel findings, including evidence of greater amplitude in the P1 component of the neural response to B ---Y chromatic stimuli in the ADHD group, together with a significant positive relationship between severity of inattention symptoms and the P1 amplitude for B ---Y stimuli. The magnitude of this group difference in P1 amplitude was notably larger for blue---yellow chromatic stimuli compared to that for red---green stimuli (e.g., Cohen's d for B ---Y was 0.80; and for R ---G was 0.11). This finding is in line with a previous finding that found hypersensitivity for the blue/yellow stimuli in children with reading disabilities. 16 Although the intergroup difference in the P1 amplitude for B ---Y stimuli appears to be driven primarily by the adolescents with ADHD who were being treated with stimulant medication, there are several reasons why we do not believe that this intergroup difference can be attributed to the effects of stimulant medication per se. First, P1 amplitude correlated positively with the SWAN inattention scores (see Fig. 3 ) and the medicated ADHD subgroup showed higher SWAN inattention scores than the non-medicated ADHD group albeit non-significantly (see Table 1 ), which may suggest that medicated ADHD group manifest more severe ADHD symptoms that required treatment with medication. Second, participants in the 'medicated' group had been asked to stop their medication for at least 24 h before the test session and indicated that they had done so, although we were unable to confirm this was the case. Thus, we believe that our findings indicate that the ADHD group ---particularly those with more severe inattentive symptoms ---manifest greater P1 amplitude for B ---Y stimuli than controls, but do not differ in P1 latency or amplitude for R ---G stimuli. This interpretation is further supported by the specific and positive correlation between the severity of inattention and P1 amplitude for B ---Y stimuli.
Evidence of greater amplitude in P1 in response to blue---yellow chromatic stimuli in the adolescents with ADHD suggests a greater involvement of their ventral extrastriate cortex of the fusiform gyrus. 20 Based on the various brain imaging and cellular level studies that suggest that color perception and processing is localized in the extrastrate area, 21, 22 we can assume that adolescents with ADHD are challenged in processing color information, hence require greater activation in the area. The larger P1 amplitude for blue---yellow stimuli might be understood as a compensation mechanism for a color deficiency that ADHD adolescents developed over time. In other words, it might be a way of compensating for problems at the receptor level such as relatively scarce number of short wavelength sensitive cones and vulnerability due to low dopamine. 37 Cortical maturation in ADHD population is delayed compared to healthy children. 3 We acknowledge the limitations of this pilot study, which need to be taken into account when interpreting the findings. Sample sizes were small particularly for the comparison of the two ADHD subgroups, which limits the generalizability of the findings and necessitates their replication in larger samples. Furthermore, we acknowledge that high level of inter-subject variability in VEP measure has been reported, 38 and that repeatability of the VEP responses was not tested, which weakens our findings for P1 amplitude. However, a previous study using the same VEP system and method reported good repeatability of test results. 33 Also, in this pilot study, we were not able to disentangle the effects of medication and severity of ADHD symptoms (according to the SWAN scores). Although we were able to confirm which participants were being treated with medication, we were unable to confirm whether they had stopped medication at least 24 h prior to the study as requested. Moreover, we acknowledge that this duration of washout may not be sufficient to eliminate any residual central (or retinal) effects of medication. We attempted to deal with the possible confound of medication by comparing those who were and were not being treated with medication. We believe that observed differences in the P1 response to B ---Y stimuli in the two ADHD groups may not be attributable to the effects of medication, because it is quite possible that those receiving medication differ in a systematic way from those not receiving mediation (i.e. more severe ADHD symptoms). Also, it is possible that the VEP latency and amplitude measured in the occipital lobe may not capture the impairment at a receptor level caused by hypo-dopaminergic condition in ADHD group. For instance, use of a clinical electroretinogram technique, a tool to detect and quantify central cone function, especially in disease stages with no or subtle visible retinal changes, might be an option. That approach would provide direct observation of the effect of low dopamine condition in the retina, particularly to blue and yellow cones.
Despite the limitations, we believe our preliminary findings are provocative and provide a basis for future investigations on this topic. Future studies should include different age groups and more precise and effective tests to assess neural and behavioral components of color perception, and investigate the effects of attention on color perception of B ---Y versus R ---G chromatic stimuli.
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Appendix A. Literature summary on visual function in ADHD
